LOUIS JEROME FITZPATRICK, III
Pilots at Heatherfield Dr, Souderton, PA
License number
Pennsylvania A2666072
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
205 Heatherfield Dr, Souderton, PA 18964
Personal information
See more information about LOUIS JEROME FITZPATRICK at radaris.comName
Address
Phone
205 Heatherfield Dr, Souderton, PA 18964
643 Olympia Hills Cir, Berwyn, PA 19312
205 Heatherfield Dr, Souderton, PA 18964
131 Carters Grv, Malvern, PA 19355
243 Linton Hill Rd, Duncannon, PA 17020
Professional information
See more information about LOUIS JEROME FITZPATRICK at trustoria.com
Louis Fitzpatrick - Souderton, PA
Louis Fitzpatrick - Souderton, PA
Work:
Novartis Pharmaceuticals Corporation
Associate Director/NA Regional Category Manager Progressive Engineering & Design, Inc - Fort Washington, PA
Director, Business Operations Johnson and Johnson, Inc - New Brunswick, NJ
Manager, Strategic Sourcing Strategic Sourcing, Scientific Supplies, Equipment and Services
Manager R.W. Johnson Pharmaceutical Research Institute
Senior Associate Scientist / Scientist Johnson-Matthey Inc - Malvern, PA
Development Chemist/Process Supervisor
Associate Director/NA Regional Category Manager Progressive Engineering & Design, Inc - Fort Washington, PA
Director, Business Operations Johnson and Johnson, Inc - New Brunswick, NJ
Manager, Strategic Sourcing Strategic Sourcing, Scientific Supplies, Equipment and Services
Manager R.W. Johnson Pharmaceutical Research Institute
Senior Associate Scientist / Scientist Johnson-Matthey Inc - Malvern, PA
Development Chemist/Process Supervisor
Education:
St. Joseph's University - Philadelphia, PA
Master of Science in Chemistry Lebanon Valley College - Annville, PA
Bachelor of Science in Chemistry United Friends School - Quakertown, PA
Finance Chair
Master of Science in Chemistry Lebanon Valley College - Annville, PA
Bachelor of Science in Chemistry United Friends School - Quakertown, PA
Finance Chair
Substituted Aminoalkylamide Derivatives As Antagonists Of Follicle Stimulating Hormone
Substituted Aminoalkylamide Derivatives As Antagonists Of Follicle Stimulating Hormone
US Patent:
6583179, Jun 24, 2003
Filed:
Dec 21, 2000
Appl. No.:
09/745283
Inventors:
Steven J. Coats - Quakertown PA
Louis J. Fitzpatrick - Souderton PA
Dennis J. Hlasta - Doylestown PA
Carolina L. Lanter - Flemington PA
Mark J. Macielag - Branchburg NJ
Ke Pan - Phoenixville PA
Ralph A. Rivero - Northwales PA
Stephen S. Palmer - Plympton MA
Louis J. Fitzpatrick - Souderton PA
Dennis J. Hlasta - Doylestown PA
Carolina L. Lanter - Flemington PA
Mark J. Macielag - Branchburg NJ
Ke Pan - Phoenixville PA
Ralph A. Rivero - Northwales PA
Stephen S. Palmer - Plympton MA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 3118
US Classification:
514603, 51421703, 51421704, 51425212, 51425213, 514316, 514318, 514327, 514330, 514311, 514312, 514314, 514444, 514445, 514447, 514459, 514460, 540597, 544359, 544361, 544366, 546152, 546155, 546156, 546186
Abstract:
The present invention is directed to a series of novel substituted aminoalkylamide derivatives, pharmaceutical compositions containing them and their use in the treatment of reproductive disorders and affective conditions. Further, the compounds of the invention are antagonists of follicle stimulating hormone, a hormone associated with the human reproductive system.
4-[Aryl(Piperidin-4-Yl)]Aminobenzamides
4-[Aryl(Piperidin-4-Yl)]Aminobenzamides
US Patent:
6436959, Aug 20, 2002
Filed:
Dec 23, 1998
Appl. No.:
09/220189
Inventors:
John R. Carson - Norristown PA
Richard J. Carmosin - late of Quakertown PA
Louis J. Fitzpatrick - Souderton PA
Allen B. Reitz - Lansdale PA
Michele C. Jetter - Norristown PA
Richard J. Carmosin - late of Quakertown PA
Louis J. Fitzpatrick - Souderton PA
Allen B. Reitz - Lansdale PA
Michele C. Jetter - Norristown PA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 314468
US Classification:
514326, 514329, 546224, 546208
Abstract:
4-[aryl(piperidin-4-yl)]aminobenzamides are delta-opioid receptor agonists/antagonists. As delta-opioid receptor agonists, such compounds are useful as analgesics. Depending on their agonist/antagonist effect, such compounds may also be useful immunosuppressants, antiinflammatory agents, agents for the treatment of mental illness, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents, and agents for the treatment of respiratory diseases.
1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
US Patent:
8501791, Aug 6, 2013
Filed:
Jul 13, 2010
Appl. No.:
12/835220
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharamaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/433, C07D 285/08
US Classification:
514361, 548125, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
Novel 1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
Novel 1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
US Patent:
2006003, Feb 9, 2006
Filed:
Sep 27, 2005
Appl. No.:
11/236097
Inventors:
Magdalena Elsinger - Demarest NJ, US
Louis Fitzpatrick - Souderton PA, US
Daniel Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Louis Fitzpatrick - Souderton PA, US
Daniel Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
International Classification:
C07D 285/08, A61K 31/433
US Classification:
514361000, 548128000
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
1,2,4-Thiadiazolium Derivatives As Melanocortin Receptor Modulators
US Patent:
7319107, Jan 15, 2008
Filed:
Nov 4, 2002
Appl. No.:
10/287096
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Johnson & Johnson Consumer Companies, Inc. - Skillman NJ
International Classification:
A61K 31/433, C07D 285/08
US Classification:
514361, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
5-?(Heteroaryl)Alkyl!-3-Oxo-Pyrido?1,2-A!Benzimidazole-4-Carboxamide Derivatives Useful In Treating Central Nervous System Disorders
5-?(Heteroaryl)Alkyl!-3-Oxo-Pyrido?1,2-A!Benzimidazole-4-Carboxamide Derivatives Useful In Treating Central Nervous System Disorders
US Patent:
5922731, Jul 13, 1999
Filed:
Jun 30, 1997
Appl. No.:
8/884804
Inventors:
Allen B. Reitz - Lansdale PA
Louis J. Fitzpatrick - Souderton PA
Alfonzo D. Jordan - Horsham PA
Pauline J. Sanfilippo - Chester Springs PA
Louis J. Fitzpatrick - Souderton PA
Alfonzo D. Jordan - Horsham PA
Pauline J. Sanfilippo - Chester Springs PA
Assignee:
Ortho Pharmaceutical Corporation - Raritan NJ
International Classification:
A61K 3144, C07D47100, C07D49800, C07D51300
US Classification:
514292
Abstract:
A compound of the general formula 1; ##STR1## is disclosed as useful in treating disorders of the central nervous system. Pharmaceutical compositions and methods of treatment are also disclosed.
1,2,4-Thiadiazole Derivatives As Melanocortin Receptor Modulators
1,2,4-Thiadiazole Derivatives As Melanocortin Receptor Modulators
US Patent:
7049331, May 23, 2006
Filed:
Nov 4, 2002
Appl. No.:
10/287095
Inventors:
Magdalena Eisinger - Demarest NJ, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Louis J. Fitzpatrick - Souderton PA, US
Daniel H. Lee - Sudbury MA, US
Kevin Pan - Phoenixville PA, US
Carlos Plata-Salaman - Ambler PA, US
Allen B. Reitz - Lansdale PA, US
Boyu Zhao - Lansdale PA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/433, C07D 285/08
US Classification:
514361, 548125, 548128
Abstract:
The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
Substituted Aminoalkylamide Derivatives As Antagonists Of Follicle Stimulating Hormone
Substituted Aminoalkylamide Derivatives As Antagonists Of Follicle Stimulating Hormone
US Patent:
2004009, May 13, 2004
Filed:
Apr 14, 2003
Appl. No.:
10/412860
Inventors:
Steven Coats - Quakertown PA, US
Louis Fitzpatrick - Souderton PA, US
Dennis Hlasta - Doylestown PA, US
Carolina Lanter - Flemington NJ, US
Mark Macielag - Branchburg NJ, US
Ke Pan - Phoenixville PA, US
Ralph Rivero - Northwales PA, US
Stephen Palmer - Plympton MA, US
Louis Fitzpatrick - Souderton PA, US
Dennis Hlasta - Doylestown PA, US
Carolina Lanter - Flemington NJ, US
Mark Macielag - Branchburg NJ, US
Ke Pan - Phoenixville PA, US
Ralph Rivero - Northwales PA, US
Stephen Palmer - Plympton MA, US
International Classification:
A61K031/55, A61K031/541, A61K031/538, A61K031/5377, A61K031/496, A61K031/4545, C07D417/14, C07D413/14, C 07D 4 3/14
US Classification:
514/217030, 514/227800, 514/235500, 514/253010, 514/316000, 514/230500, 540/598000, 544/060000, 544/105000, 544/360000, 544/129000, 546/186000, 546/187000
Abstract:
The present invention is directed to a series of novel substituted aminoalkylamide derivatives, pharmaceutical compositions containing them and their use in the treatment of reproductive disorders and affective conditions. Further, the compounds of the invention are antagonists of follicle stimulating hormone, a hormone associated with the human reproductive system.
Anti-Inflammatory Compounds
Anti-Inflammatory Compounds
US Patent:
2002010, Aug 1, 2002
Filed:
Jan 8, 2002
Appl. No.:
10/041423
Inventors:
Malcolm Scott - Lansdale PA, US
Pauline Sanfilippo - Chester Springs PA, US
Louis Fitzpatrick - Souderton PA, US
Richard Cordova - Whitehall PA, US
Kevin Pan - Wayne PA, US
Joseph Meschino - Avalon NJ, US
Pauline Sanfilippo - Chester Springs PA, US
Louis Fitzpatrick - Souderton PA, US
Richard Cordova - Whitehall PA, US
Kevin Pan - Wayne PA, US
Joseph Meschino - Avalon NJ, US
International Classification:
C07D335/10, C07D311/82, C07D219/10, C 07D 4 9/02, C 07D 4 7/02, A61K031/473
US Classification:
514/278000, 514/297000, 514/337000, 514/409000, 514/422000, 514/437000, 514/454000, 546/016000, 546/018000, 546/104000, 546/280100, 546/282700, 548/407000, 548/517000, 549/026000, 549/331000, 549/060000, 549/390000
Abstract:
This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure: